Immunotherapy has become a powerful clinical strategy for treating cancer. The number of
immunotherapy drug approvals has been increasing, with numerous treatments in clinical …

Intracellular delivery is a key step in biological research and has enabled decades of
biomedical discoveries. It is also becoming increasingly important in industrial and medical …

The translational potential of cell-based therapies is often limited by complications related to
effectively engineering and manufacturing functional cells. While the use of electroporation …

Reactive oxygen species (ROS) have been long considered simply as harmful by-products
of metabolism, which damage cellular proteins, lipids, and nucleic acids. ROS are also …

Immunotherapy has become an emerging strategy for the treatment of cancer.
Immunotherapeutic drugs have been increasing for clinical treatment. Despite significant …

Cancer immunotherapy has veered the paradigm of cancer treatment. Despite recent
advances in immunotherapy for improved antitumor efficacy, the complicated tumor …

Intracellular delivery is considered an indispensable process for various studies, ranging
from medical applications (cell‐based therapy) to fundamental (genome‐editing) and …

Chimeric antigen receptor T cell (CAR‐T) therapy holds great promise for preventing and
treating deadly diseases such as cancer. However, it remains challenging to transfect and …

Cell‐based living materials, including single cells, cell‐laden fibers, cell sheets, organoids,
and organs, have attracted intensive interests owing to their widespread applications in …

The intracellular delivery of proteins is of great significance. For diseases such as cancer,
heart disease and neurodegenerative diseases, many important pharmacological targets …